May 15, 2018

DUBLIN, IRELAND – May 15, 2018 – ATXA Therapeutics Limited, an Irish company developing novel therapeutic drugs for the treatment of Pulmonary Arterial Hypertension (PAH) and for other related cardiovascular conditions, has secured €2.5 million funding under the Europe...

May 10, 2018

DUBLIN, IRELAND – May 10, 2018 – Founder & Chief Scientific Officer of ATXA Therapeutics, Prof. Therese Kinsella, attended a reception with the President of Ireland Michael D. Higgins and his wife Sabina Higgins, at Áras an Uachtaráin on Friday, May 4th, 2018.

The recep...

Please reload

Recent Posts

September 30, 2019

Please reload

Please reload

Search By Tags
Please reload

© 2020 by ATXA Therapeutics Limited.

Dublin, Ireland

Home  |  About Us  |  News  |  Contact Us

Follow us on:

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon